Niclas Eriksson

Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Ås, Joel; Bertulyte, Ilma; Norgren, Nina; Johansson, Anna et al.

Ingår i PLOS ONE, 2024

• DOI för Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs
• Ladda ner fulltext (pdf) av Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.

Bhandage, Amol; Kenina, Viktorija; Huang, Yu-Fang; Roddate, Marija et al.

Ingår i iScience, s. 110564, 2024

• DOI för Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
• Ladda ner fulltext (pdf) av Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

James, Stefan; Erlinge, David; Storey, Robert F; McGuire, Darren K et al.

Ingår i NEJM evidence, 2024

• DOI för Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Attelind, Sofia; Eriksson, Niclas; Sundstroem, A.; Wadelius, Mia et al.

Ingår i Pharmacoepidemiology and Drug Safety, 2024

• DOI för Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Ås, Joel; Bertulyte, Ilma; Norgren, Nina; Johansson, Anna et al.

Ingår i PLOS ONE, 2024

• DOI för Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs
• Ladda ner fulltext (pdf) av Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.

Bhandage, Amol; Kenina, Viktorija; Huang, Yu-Fang; Roddate, Marija et al.

Ingår i iScience, s. 110564, 2024

• DOI för Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.
• Ladda ner fulltext (pdf) av Serum protein biomarker profile distinguishes acetylcholine receptor antibody seropositive myasthenia gravis patients from healthy controls.

Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

James, Stefan; Erlinge, David; Storey, Robert F; McGuire, Darren K et al.

Ingår i NEJM evidence, 2024

• DOI för Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure.

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Attelind, Sofia; Eriksson, Niclas; Sundstroem, A.; Wadelius, Mia et al.

Ingår i Pharmacoepidemiology and Drug Safety, 2024

• DOI för Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Ås, Joel; Bertulyte, Ilma; Norgren, Nina; Johansson, Anna et al.

Ingår i PLOS ONE, 2024

• DOI för Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs
• Ladda ner fulltext (pdf) av Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs

Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Attelind, Sofia; Eriksson, Niclas; Sundström, Anders; Wadelius, Mia et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 1431-1438, 2023

• DOI för Identification of risk factors for adverse drug reactions in a pharmacovigilance database
• Ladda ner fulltext (pdf) av Identification of risk factors for adverse drug reactions in a pharmacovigilance database

Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

Zhao, Jing Hua; Stacey, David; Eriksson, Niclas; Macdonald-Dunlop, Erin et al.

Ingår i Nature Immunology, s. 1540-1551, 2023

• DOI för Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
• Ladda ner fulltext (pdf) av Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets

Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Davidsson, Pia; Eketjall, Susanna; Eriksson, Niclas; Walentinsson, Anna et al.

Ingår i Cardiovascular Research, s. 1596-1605, 2023

• DOI för Vascular endothelial growth factor-D plasma levels and VEGFD genetic variants are independently associated with outcomes in patients with cardiovascular disease

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Siegbahn, Agneta; Eriksson, Niclas; Assarsson, Erika; Lundberg, Martin et al.

Ingår i PLOS ONE, 2023

• DOI för Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)
• Ladda ner fulltext (pdf) av Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

Zhao, Jing Hua; Stacey, David; Eriksson, Niclas; Macdonald-Dunlop, Erin et al.

Ingår i Nature Immunology, s. 1960, 2023

• DOI för Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.

Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

Ollila, Hanna M.; Sharon, Eilon; Lin, Ling; Sinnott-Armstrong, Nasa et al.

Ingår i Nature Communications, 2023

• DOI för Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
• Ladda ner fulltext (pdf) av Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy

Risk of Revision After Arthroplasty Associated with Specific Gene Loci: A Genomewide Association Study of Single-Nucleotide Polymorphisms in 1,130 Twins Treated with Arthroplasty

Brüggemann, Anders; Eriksson, Niclas; Michaëlsson, Karl; Hailer, Nils P.

Ingår i Journal of Bone and Joint Surgery. American volume, s. 610-620, 2022

• DOI för Risk of Revision After Arthroplasty Associated with Specific Gene Loci: A Genomewide Association Study of Single-Nucleotide Polymorphisms in 1,130 Twins Treated with Arthroplasty
• Ladda ner fulltext (pdf) av Risk of Revision After Arthroplasty Associated with Specific Gene Loci: A Genomewide Association Study of Single-Nucleotide Polymorphisms in 1,130 Twins Treated with Arthroplasty

Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.

Ingår i Biomedicines, 2022

• DOI för Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients
• Ladda ner fulltext (pdf) av Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients

Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

Cavalli, Marco; Eriksson, Niclas; Karlsson Sundbaum, Johanna; Wallenberg, Matilda et al.

Ingår i Pharmacogenomics (London), s. 813-820, 2022

• DOI för Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate
• Ladda ner fulltext (pdf) av Genome-wide association study of liver enzyme elevation in an extended cohort of rheumatoid arthritis patients starting low-dose methotrexate

HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease

Ås, Joel; Bertulyte, Ilma; Eriksson, Niclas; Magnusson, Patrik K. E. et al.

Ingår i Clinical and Translational Science, s. 1249-1256, 2022

• DOI för HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease
• Ladda ner fulltext (pdf) av HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease

AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Vessby, Johan; Wisniewski, Jacek R.; Lindskog, Cecilia; Eriksson, Niclas et al.

Ingår i Clinical and Translational Gastroenterology, 2022

• DOI för AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Schillemans, Tessa; Tragante, Vinicius; Maitusong, Buamina; Gigante, Bruna et al.

Ingår i Frontiers in Physiology, 2022

• DOI för Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
• Ladda ner fulltext (pdf) av Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis

Genetic Landscape of the ACE2 Coronavirus Receptor

Yang, Zhijian; Macdonald-Dunlop, Erin; Chen, Jiantao; Zhai, Ranran et al.

Ingår i Circulation, s. 1398-1411, 2022

• DOI för Genetic Landscape of the ACE2 Coronavirus Receptor
• Ladda ner fulltext (pdf) av Genetic Landscape of the ACE2 Coronavirus Receptor

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Sjölin, Karl; Aulin, Julia; Wallentin, Lars; Eriksson, Niclas et al.

Ingår i Journal of the American Heart Association, 2022

• DOI för Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
• Ladda ner fulltext (pdf) av Serum Neurofilament Light Chain in Patients With Atrial Fibrillation

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events

Attelind, Sofia; Hallberg, Pär; Wadelius, Mia; Hamberg, Anna-Karin et al.

Ingår i Frontiers in Genetics, 2022

• DOI för Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
• Ladda ner fulltext (pdf) av Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events

Similar risk of cancer in patients younger than 55 years with or without a total hip arthroplasty (THA): a population-based cohort study on 18,771 exposed to THA and 87,683 controls

Hailer, Yasmin; Kärrholm, Johan; Eriksson, Niclas; Holmberg, Lars et al.

Ingår i Acta Orthopaedica, s. 317-326, 2022

• DOI för Similar risk of cancer in patients younger than 55 years with or without a total hip arthroplasty (THA): a population-based cohort study on 18,771 exposed to THA and 87,683 controls
• Ladda ner fulltext (pdf) av Similar risk of cancer in patients younger than 55 years with or without a total hip arthroplasty (THA): a population-based cohort study on 18,771 exposed to THA and 87,683 controls

Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.

Ingår i Nephrology, Dialysis and Transplantation, s. 1162-1170, 2021

• DOI för Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis

Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Kohnke, Hugo et al.

Ingår i Pharmacogenomics (London), s. 973-982, 2021

• DOI för Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate
• Ladda ner fulltext (pdf) av Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate

Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Schunk, Stefan J.; Kleber, Marcus E.; März, Winfried; Pang, Shichao et al.

Ingår i European Heart Journal, s. 1742-1756, 2021

• DOI för Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality

Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

Mahmoodi, Bakhtawar K.; Eriksson, Niclas; Ross, Stephanie; Claassens, Daniel M. F. et al.

Ingår i Journal of the American Heart Association, 2021

• DOI för Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials
• Ladda ner fulltext (pdf) av Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Wallentin, Lars; Eriksson, Niclas; Olszowka, Maciej; Grammer, Tanja et al.

Ingår i PLoS Medicine, 2021

• DOI för Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
• Ladda ner fulltext (pdf) av Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study

Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors

Ghouse, Jonas; Ahlberg, Gustav; Andreasen, Laura; Banasi, Karina et al.

Ingår i Journal of the American College of Cardiology, s. 696-709, 2021

• DOI för Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors

Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

Mahmoodi, Bakhtawar K.; Eriksson, Niclas; Vos, Gerrit J. A.; Meijer, Karina et al.

Ingår i Journal of the American Heart Association, 2021

• DOI för Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis
• Ladda ner fulltext (pdf) av Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis

Patient-reported Outcome in Surgically Treated Pelvic Ring Injuries at 5 Years Post-surgery

Hernefalk, Björn; Eriksson, Niclas; Larsson, Sune; Borg, Tomas

Ingår i Scandinavian Journal of Surgery, s. 86-92, 2021

• DOI för Patient-reported Outcome in Surgically Treated Pelvic Ring Injuries at 5 Years Post-surgery

Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19

Klaric, Lucija; Gisby, Jack S; Papadaki, Artemis; Muckian, Marisa D et al.

Ingår i medRxiv : the preprint server for health sciences, s. 1-28, 2021

• DOI för Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19

Exome sequencing reveals common and rare variants in F5 associated with ACE inhibitor and angiotensin receptor blocker-induced angioedema

Maroteau, Cyrielle; Siddiqui, Moneeza Kalhan; Veluchamy, Abirami; Carr, Fiona et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 1195-1202, 2020

• DOI för Exome sequencing reveals common and rare variants in F5 associated with ACE inhibitor and angiotensin receptor blocker-induced angioedema
• Ladda ner fulltext (pdf) av Exome sequencing reveals common and rare variants in F5 associated with ACE inhibitor and angiotensin receptor blocker-induced angioedema

Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations

Cismaru, Anca Liliana; Rudin, Deborah; Ibanez, Luisa; Liakoni, Evangelia et al.

Ingår i Genes, 2020

• DOI för Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations
• Ladda ner fulltext (pdf) av Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations

Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Mahmoodi, Bakhtawar K.; Tragante, Vinicius; Kleber, Marcus E.; Holmes, Michael V. et al.

Ingår i Circulation, s. 546-555, 2020

• DOI för Association of Factor V Leiden With Subsequent Atherothrombotic Events A GENIUS-CHD Study of Individual Participant Data

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.

Morales-Rosado, Joel A; Goel, Kashish; Zhang, Lingxin; Åkerblom, Axel et al.

Ingår i Cardiovascular Drugs and Therapy, s. 549-559, 2020

• DOI för Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics.

Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.

Wallentin, Lars; Lindbäck, Johan; Eriksson, Niclas; Hijazi, Ziad et al.

Ingår i European Heart Journal, s. 4037-4046, 2020

• DOI för Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Folkersen, Lasse; Gustafsson, Stefan; Wang, Qin; Hvidberg Hansen, Daniel et al.

Ingår i Nature Metabolism, s. 1135-1148, 2020

• DOI för Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

Hailer, Nils P.; Garland, Anne; Gordon, Max; Karrholm, Johan et al.

Ingår i International Journal of Cancer, s. 76-83, 2020

• DOI för No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis
• Ladda ner fulltext (pdf) av No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Karlsson Sundbaum, Johanna; Baecklund, Eva; Eriksson, Niclas; Hallberg, Pär et al.

Ingår i Pharmacogenomics (London), s. 337-346, 2020

• DOI för MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis

Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice

Karlsson Sundbaum, Johanna; Eriksson, Niclas; Hallberg, Pär; Lehto, Niklas et al.

Ingår i INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, s. 1226-1232, 2019

• DOI för Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice
• Ladda ner fulltext (pdf) av Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice

Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Patel, Riyaz S.; Schmidt, Amand F.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data
• Ladda ner fulltext (pdf) av Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events: A GENIUS-CHD Study of Individual Participant Data

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention

Kessler, Thorsten; Wolf, Bernhard; Eriksson, Niclas; Kofink, Daniel et al.

Ingår i Cardiovascular Research, s. 1512-1518, 2019

• DOI för Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention

Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

Parker, William A E; Eriksson, Niclas; Becker, Richard C; Voora, Deepak et al.

Ingår i Platelets, s. 579-588, 2019

• DOI för Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study

Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Patel, Riyaz S.; Tragante, Vinicius; Schmidt, Amand F.; McCubrey, Raymond O. et al.

Ingår i Circulation, 2019

• DOI för Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium
• Ladda ner fulltext (pdf) av Subsequent Event Risk in Individuals With Established Coronary Heart Disease: Design and Rationale of the GENIUS-CHD Consortium

Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

Hallberg, Pär; Smedje, Hans; Eriksson, Niclas; Kohnke, Hugo et al.

Ingår i EBioMedicine, s. 595-604, 2019

• DOI för Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival
• Ladda ner fulltext (pdf) av Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival

A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

Kharazmi, Mohammad; Michaëlsson, Karl; Schilcher, Jorg; Eriksson, Niclas et al.

Ingår i Calcified Tissue International, s. 51-67, 2019

• DOI för A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture
• Ladda ner fulltext (pdf) av A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture

Novel Cyp2C19 Genetic Variants associated with Stent Thrombosis: a Next Generation Sequencing Study

Goel, Kashish; Baheti, Saurabh; Åkerblom, Axel; Eriksson, Niclas et al.

Ingår i Journal of the American College of Cardiology, s. 1205-1205, 2018

• DOI för Novel Cyp2C19 Genetic Variants associated with Stent Thrombosis: a Next Generation Sequencing Study

Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Wadelius, Mia; Eriksson, Niclas; Kreutz, Reinhold; Bondon-Guitton, Emmanuelle et al.

Ingår i Clinical Pharmacology and Therapeutics, s. 843-853, 2018

• DOI för Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.
• Ladda ner fulltext (pdf) av Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus.

Genome‐Wide Association Study of Pandemrix‐Induced Narcolepsy in Sweden – A Possible Role for Glial Derived Neurotrophic Factor (GDNF)

Wadelius, Mia; Eriksson, Niclas; Smedje, H.; Yue, Q. -Y et al.

Ingår i Basic & Clinical Pharmacology & Toxicology, s. 12-13, 2018

• DOI för Genome‐Wide Association Study of Pandemrix‐Induced Narcolepsy in Sweden – A Possible Role for Glial Derived Neurotrophic Factor (GDNF)

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Zewinger, Stephen; Kleber, Marcus E.; Tragante, Vinicius; McCubrey, Raymond O. et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 534-543, 2017

• DOI för Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study

Whole exome sequencing in individuals with statin-induced myopathy

Bloch, K. M.; Carr, D.; Pirmohamed, M.; Morris, A. et al.

Ingår i Drug Safety, s. 1026-1026, 2017

Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population

Hallberg, Pär; Persson, Matilda; Axelsson, Tomas; Cavalli, Marco et al.

Ingår i Pharmacogenomics (London), s. 201-213, 2017

• DOI för Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population
• Ladda ner fulltext (pdf) av Genetic variants associated with angiotensin-converting enzyme inhibitor-induced cough: a genome-wide association study in a Swedish population

The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals

Ehret, Georg B.; Ferreira, Teresa; Chasman, Daniel I.; Jackson, Anne U. et al.

Ingår i Nature Genetics, s. 1171-1184, 2016

• DOI för The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

Johansson, Åsa; Eriksson, Niclas; Lindholm, Daniel; Varenhorst, Christoph et al.

Ingår i Human Molecular Genetics, s. 1447-1456, 2016

• DOI för Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome

Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose

Cavalli, Marco; Pan, Gang; Nord, Helena; Eriksson, Niclas et al.

Ingår i Pharmacogenomics (London), s. 1305-1314, 2016

• DOI för Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose
• Ladda ner fulltext (pdf) av Novel regulatory variant detected on the VKORC1 haplotype that is associated with warfarin dose

Estimating pre-traumatic quality of life in patients with surgically treated acetabular fractures and pelvic ring injuries: Does timing matter?

Hernefalk, Björn; Eriksson, Niclas; Borg, Tomas; Larsson, Sune

Ingår i Injury, s. 389-394, 2016

• DOI för Estimating pre-traumatic quality of life in patients with surgically treated acetabular fractures and pelvic ring injuries: Does timing matter?

Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

Eriksson, Niclas; Wallentin, Lars; Berglund, Lars; Axelsson, Tomas et al.

Ingår i Pharmacogenomics (London), s. 1425-1439, 2016

• DOI för Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy
• Ladda ner fulltext (pdf) av Genetic determinants of warfarin maintenance dose and time in therapeutic treatment range: a RE-LY genomics substudy

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population

Hallberg, Pär; Eriksson, Niclas; Ibanez, Luisa; Bondon-Guitton, Emmanuelle et al.

Ingår i The Lancet Diabetes and Endocrinology, s. 507-516, 2016

• DOI för Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

Varenhorst, Christoph; Eriksson, Niclas; Johansson, Åsa; Barratt, Bryan J. et al.

Ingår i European Heart Journal, s. 1901-1912, 2015

• DOI för Effect of genetic variations on ticagrelor plasma levels and clinical outcomes

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Johansson, Åsa; Eriksson, Niclas; Becker, Richard C.; Storey, Robert F. et al.

Ingår i Circulation, s. 498-506, 2015

• DOI för NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome

Johansson, Åsa; Alfredsson, Jenny; Eriksson, Niclas; Wallentin, Lars et al.

Ingår i PLOS ONE, 2015

• DOI för Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome
• Ladda ner fulltext (pdf) av Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome

Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Ross, Stephanie; Eikelboom, John; Anand, Sonia S.; Eriksson, Niclas et al.

Ingår i European Heart Journal, s. 2242-2248, 2014

• DOI för Association of cyclooxygenase-2 genetic variant with cardiovascular disease

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet Inhibition and Patient Outcomes (PLATO) Study

Åkerblom, Axel; Eriksson, Niclas; Wallentin, Lars; Siegbahn, Agneta et al.

Ingår i American Heart Journal, s. 96-102, 2014

• DOI för Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet Inhibition and Patient Outcomes (PLATO) Study

Waran doseras bättre efter genanalys

Wadelius, Mia; Eriksson, Niclas

Ingår i Läkartidningen, s. 22-22, 2014

Large-scale association analysis identifies new risk loci for coronary artery disease

Deloukas, Panos; Kanoni, Stavroula; Willenborg, Christina; Farrall, Martin et al.

Ingår i Nature Genetics, s. 25-33, 2013

• DOI för Large-scale association analysis identifies new risk loci for coronary artery disease

Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin

Wieloch, Mattias; Jonsson, Karl M.; Sjalander, Anders; Lip, Gregory Y. H. et al.

Ingår i Thrombosis Research, s. 481-486, 2013

• DOI för Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin

Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding

Paré, Guillaume; Eriksson, Niclas; Lehr, Thorsten; Connolly, Stuart et al.

Ingår i Circulation, s. 1404, 2013

• DOI för Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding

A Randomized Trial of Genotype-Guided Dosing of Warfarin

Pirmohamed, Munir; Burnside, Girvan; Eriksson, Niclas; Jorgensen, Andrea L. et al.

Ingår i New England Journal of Medicine, s. 2294-2303, 2013

• DOI för A Randomized Trial of Genotype-Guided Dosing of Warfarin

Graft Loss Risk in Renal Transplant Recipients with Metabolic Syndrome: Subgroup Analyses of the ALERT Trial

Soveri, Inga; Abedini, Sadollah; Holdaas, Halvard; Jardine, Alan et al.

Ingår i JN. Journal of Nephrology (Milano. 1992), s. 245-254, 2012

• DOI för Graft Loss Risk in Renal Transplant Recipients with Metabolic Syndrome: Subgroup Analyses of the ALERT Trial

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

Horne, B D; Lenzini, P A; Wadelius, Mia; Jorgensen, A L et al.

Ingår i Thrombosis and Haemostasis, s. 232-240, 2012

• DOI för Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

Wieloch, Mattias; Själander, Anders; Frykman, Viveka; Rosenqvist, Mårten et al.

Ingår i European Heart Journal, s. 2282-2289, 2011

• DOI för Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

Association of Admission Blood Glucose and Outcome in Patients Treated With Intravenous Thrombolysis

Ahmed, Niaz; Davalos, Antoni; Eriksson, Niclas; Ford, Gary A. et al.

Ingår i Archives of Neurology, s. 1123-1130, 2010

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups

Limdi, Nita A.; Wadelius, Mia; Cavallari, Larissa; Eriksson, Niclas et al.

Ingår i Blood, s. 3827-3834, 2010

• DOI för Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across three racial groups

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

Takeuchi, Fumihiko; McGinnis, Ralph; Bourgeois, Stephane; Eriksson, Niclas et al.

Ingår i PLoS genetics, 2009

• DOI för A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

Estimation of the warfarin dose with clinical and pharmacogenetic data

Klein, T. E.; Altman, R. B.; Eriksson, Niclas; Gage, B. F. et al.

Ingår i New England Journal of Medicine, s. 753-764, 2009

• DOI för Estimation of the warfarin dose with clinical and pharmacogenetic data

The largest prospective warfarin-treated cohort supports genetic forecasting

Wadelius, Mia; Chen, Leslie Y.; Lindh, Jonatan D.; Eriksson, Niclas et al.

Ingår i Blood, s. 784-792, 2009

• DOI för The largest prospective warfarin-treated cohort supports genetic forecasting

Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment

Soveri, Inga; Abedini, Sadollah; Holdaas, Hallvard; Jardine, Alan et al.

Ingår i Clinical Transplantation, s. 914-920, 2009

• DOI för Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment

Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)

Wahlgren, Nils; Ahmed, Niaz; Eriksson, Niclas; Aichner, Franz et al.

Ingår i Stroke, s. 3316-3322, 2008

• DOI för Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)

Surgical and long-term mortality in 2634 consecutive patients operated on the proximal thoracic aorta

Olsson, Christian; Eriksson, Niclas; Ståhle, Elisabeth; Thelin, Stefan

Ingår i European Journal of Cardio-Thoracic Surgery, s. 963-969, 2007

• DOI för Surgical and long-term mortality in 2634 consecutive patients operated on the proximal thoracic aorta

Association of warfarin dose with genes involved in its action and metabolism

Wadelius, Mia; Chen, Leslie Y.; Eriksson, Niclas; Bumpstead, Suzannah et al.

Ingår i Human Genetics, s. 23-34, 2007

• DOI för Association of warfarin dose with genes involved in its action and metabolism

The Swedish Heart Surgery Register: Data quality for proximal thoracic aortic operations

Olsson, Christian; Eriksson, Niclas; Ståhle, Elisabeth; Thelin, Stefan

Ingår i Scandinavian Cardiovascular Journal, s. 348-353, 2006

• DOI för The Swedish Heart Surgery Register: Data quality for proximal thoracic aortic operations

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

Wadelius, Mia; Chen, L.Y.; Downes, K.; Ghori, J. et al.

Ingår i The Pharmacogenomics Journal, s. 262-70, 2005

• DOI för Common VKORC1 and GGCX polymorphisms associated with warfarin dose

Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

Chen, Leslie Y.; Eriksson, Niclas; Gwilliam, Rhian; Bentley, David et al.

Ingår i Blood, s. 3673-4, 2005

• DOI för Gamma-glutamyl carboxylase (GGCX) microsatellite and warfarin dosing

Prediction of warfarin dose: why, when and how?

Eriksson, Niclas; Wadelius, Mia

Ingår i Pharmacogenomics (London), s. 429-440, 2012

• DOI för Prediction of warfarin dose: why, when and how?

On the Prediction of Warfarin Dose

Eriksson, Niclas

2012

• Ladda ner fulltext (pdf) av On the Prediction of Warfarin Dose

Network-Based Analysis of Protein Interactions among Drugs and Adverse Reactions: Identifying Phenotype-Groupings and Key Genes

Ås, Joel; Eriksson, Niclas; Hallberg, Pär; Wadelius, Mia

A two-step proteomic approach identifies candidate biomarker in ulcerative colitis with concomitant primary sclerosing cholangitis.

Vessby, Johan; Wisniewski, Jacek; Eriksson, Niclas; Gabrysch, Katja et al.

Novel biomarkers detected by proteomics predict death and cardiovascular events in hemodialysis patients

Wu, Ping-Hsun; Glerup, Rie Io; Svensson, My Hanna Sofia; Eriksson, Niclas et al.